Literature DB >> 21207086

Role of physicochemical properties in the activation of peroxisome proliferator-activated receptor δ.

Vinícius G Maltarollo1, Paula Homem-de-Mello, Káthia M Honorio.   

Abstract

Current researches on treatments for metabolic diseases involve a class of biological receptors called peroxisome proliferator-activated receptors (PPARs), which control the metabolism of carbohydrates and lipids. A subclass of these receptors, PPARδ, regulates several metabolic processes, and the substances that activate them are being studied as new drug candidates for the treatment of diabetes mellitus and metabolic syndrome. In this study, several PPARδ agonists with experimental biological activity were selected for a structural and chemical study. Electronic, stereochemical, lipophilic and topological descriptors were calculated for the selected compounds using various theoretical methods, such as density functional theory (DFT). Fisher's weight and principal components analysis (PCA) methods were employed to select the most relevant variables for this study. The partial least squares (PLS) method was used to construct the multivariate statistical model, and the best model obtained had 4 PCs, q ( 2 ) = 0.80 and r ( 2 ) = 0.90, indicating a good internal consistency. The prediction residues calculated for the compounds in the test set had low values, indicating the good predictive capability of our PLS model. The model obtained in this study is reliable and can be used to predict the biological activity of new untested compounds. Docking studies have also confirmed the importance of the molecular descriptors selected for this system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207086     DOI: 10.1007/s00894-010-0935-x

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  16 in total

1.  A study on the influence of molecular properties in the psychoactivity of cannabinoid compounds.

Authors:  Káthia M Honório; Albérico B F da Silva
Journal:  J Mol Model       Date:  2005-05-03       Impact factor: 1.810

2.  QSAR analysis of PPAR-gamma agonists as anti-diabetic agents.

Authors:  Anshuman Dixit; Anil K Saxena
Journal:  Eur J Med Chem       Date:  2007-03-18       Impact factor: 6.514

3.  Identification of a PPARdelta agonist with partial agonistic activity on PPARgamma.

Authors:  Richard V Connors; Zhulun Wang; Martin Harrison; Alex Zhang; Malgorzata Wanska; Steve Hiscock; Brian Fox; Michael Dore; Marc Labelle; Athena Sudom; Sheree Johnstone; Jinsong Liu; Nigel P C Walker; Anne Chai; Karen Siegler; Yang Li; Peter Coward
Journal:  Bioorg Med Chem Lett       Date:  2009-05-09       Impact factor: 2.823

4.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1988-01-15

5.  Traditional plant treatments for diabetes mellitus: pharmaceutical foods.

Authors:  C Day
Journal:  Br J Nutr       Date:  1998-07       Impact factor: 3.718

Review 6.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 7.  PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer.

Authors:  G J Murphy; J C Holder
Journal:  Trends Pharmacol Sci       Date:  2000-12       Impact factor: 14.819

8.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

9.  Theoretical study on the molecular and electronic properties of some substances used for diabetes mellitus treatment.

Authors:  Vinicius G Maltarollo; Paula Homem-de-Mello; Kathia M Honório
Journal:  J Mol Model       Date:  2009-12-12       Impact factor: 1.810

10.  Indanylacetic acids as PPAR-delta activator insulin sensitizers.

Authors:  Philip Wickens; Chengzhi Zhang; Xin Ma; Qian Zhao; John Amatruda; William Bullock; Michael Burns; Louis-David Cantin; Chih-Yuan Chuang; Thomas Claus; Miao Dai; Fernando Dela Cruz; David Dickson; Frederick J Ehrgott; Dongping Fan; Sarah Heald; Martin Hentemann; Christiana I Iwuagwu; Jeffrey S Johnson; Ellalahewage Kumarasinghe; David Ladner; Rico Lavoie; Sidney Liang; James N Livingston; Derek Lowe; Steve Magnuson; Gretchen Mannelly; Ingo Mugge; Herbert Ogutu; Susan Pleasic-Williams; Robert W Schoenleber; Jeff Shapiro; Tatiana Shelekhin; Laurel Sweet; Christopher Town; Manami Tsutsumi
Journal:  Bioorg Med Chem Lett       Date:  2007-03-23       Impact factor: 2.823

View more
  1 in total

1.  Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.

Authors:  Vinicius G Maltarollo; Marie Togashi; Alessandro S Nascimento; Kathia M Honorio
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.